- TFF Pharmaceuticals ( NASDAQ: TFFP ) has appointed Zamaneh Mikhak, M.D. as Chief Medical Officer.
- Dr. Mikhak will be responsible for the clinical development of the Company’s pipeline candidates, including the Inhaled Voriconazole Powder and Inhaled Tacrolimus Powder clinical programs.
- Dr. Mikhak most recently served as Senior Vice President, Head of Clinical Development for Cogent Biosciences, where she oversaw the clinical development function across the company’s major clinical programs.
For further details see:
TFF Pharmaceuticals names Zamaneh Mikhak as chief medical officer